Fresenius Medical Care already has access to the broadest dataset in the world on advanced kidney disease: a constantly growing collection of information from over 2 million patients, more than half a billion hemodialysis treatments, and almost 2 billion laboratory tests. Through our clinical research arm Frenova Renal Research, we want to build the largest registry of curated clinical data in the world.
In this data, we will find huge potential to improve our patients’ lives. Kidney disease, which affects approximately 10% of the adult population worldwide, is genetically complex, so it requires huge data sets like ours to evolve our understanding. What we are looking for are biomarkers that can tell us how susceptible individuals are to kidney disease and how they might respond to interventions. This will unlock the potential of precision medicine: In a much more targeted approach, we will be able to make reliable and insightful decisions specific to the individual in front of us. The right patient will get the right treatment at the right time.